PDCD1 and Sepsis: While PD-1 inhibition can reverse T cell exhaustion in sepsis, it may paradoxically amplify immunosuppressive regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) in comorbid patients, potentially leading to shorter progression-free survival when used concurrently with immunotherapy [71].